Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 83Glioma 73Glioblastoma 73Neuroblastoma 27Neoplasms 22Astrocytoma 20Neurofibromatosis 1 19Ependymoma 19Sarcoma 18Medulloblastoma 18Central Nervous System Neoplasms 18Rhabdoid Tumor 15Melanoma 15Meningioma 14Carcinoma, Non-Small-Cell Lung 14Osteosarcoma 13Wilms Tumor 12Sarcoma, Ewing 12Rhabdomyosarcoma 12Breast Neoplasms 12Neurofibroma, Plexiform 11Hepatoblastoma 11Diffuse Intrinsic Pontine Glioma 10Neuroectodermal Tumors, Primitive, Peripheral 9Lymphoma, Non-Hodgkin 9Histiocytosis, Langerhans-Cell 9Thyroid Neoplasms 8Recurrence 8Pancreatic Neoplasms 8Neoplasm Metastasis 8

Interventions

Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroma × CNS × 30 days × Clear all
NCT01083966 2026-06-01

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Northwell Health

Phase 1 Suspended
30 enrolled
CNS

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡